Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Eargo, Inc.
  6. Summary
    EAR   US2700871096

EARGO, INC.

(EAR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/02/2021 12/03/2021 12/06/2021 12/07/2021 12/08/2021 Date
5.03(c) 4.7(c) 4.98(c) 5.47(c) 5.63 Last
1 585 819 1 418 081 2 532 756 1 991 055 2 317 779 Volume
+4.57% -6.56% +5.96% +9.84% +2.93% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 86,6 M - -
Net income 2021 - - -
Net cash position 2021 169 M - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 98,7 M - -
Net income 2022 - - -
Net cash position 2022 147 M - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 221 M 221 M -
EV / Sales 2021 0,60x
EV / Sales 2022 0,75x
Nbr of Employees 238
Free-Float 86,4%
More Financials
Company
Eargo, Inc. is a medical device company that provides Eargo solution to create a hearing aid. The CompanyÔÇÖs in-the-canal devices feature audio, are designed to provide up to 16 hours of battery life and have Flexi Fibers or Flexi Palms, which are designed to enable the unit to float in the ear canal, allowing air and sound to pass freely around them. In addition, Eargo hearing aids allows its users to cycle... 
More about the company
Ratings of Eargo, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about EARGO, INC.
12/07EARGO, INC. : Costs Associated with Exit or Disposal Activities (form 8-K)
AQ
12/03EARGO 72 HOUR DEADLINE ALERT : Former Louisiana Attorney General and Kahn Swick & Foti, LL..
BU
12/02NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
12/01CLAIMSFILER ALERTS EARGO Investors of Lead Plaintiff Deadline in Class Action Lawsuits ..
PR
11/23INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claims Against ..
BU
11/22INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Ear..
BU
11/22EARGO : Receives Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q..
PU
11/22EARGO, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa..
AQ
11/22Eargo Receives Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-..
AQ
11/18FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of..
PR
11/17EARGO SHAREHOLDER ALERT : CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 ..
PR
11/17EAR CLASS ACTION : Hagens Berman Encourages Eargo (EAR) Investors with +$500k Losses to Co..
PR
11/12SHAREHOLDER INVESTIGATION : Robbins LLP Investigates Eargo, Inc. (EAR) on Behalf of Shareh..
BU
11/12EARGO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
11/05EAR INVESTIGATION REMINDER : Kessler Topaz Meltzer & Check, LLP is Investigating Securitie..
PR
More news
News in other languages on EARGO, INC.
09/23Les actions du secteur de la santé restent fermes près de la clôture de jeudi
09/23Les actions du secteur de la santé progressent jeudi après-midi
09/23Eargo abandonne ses prévisions pour 2021 alors que le ministère de la Justice ouvre une..
09/22Eargo renonce à ses prévisions pour 2021 alors que le ministère de la Justice enquête s..
09/22Eargo, Inc. retire ses prévisions financières pour l'année fiscale se terminant le 31 d..
More news
Analyst Recommendations on EARGO, INC.
More recommendations
Chart EARGO, INC.
Duration : Period :
Eargo, Inc. Technical Analysis Chart | EAR | US2700871096 | MarketScreener
Technical analysis trends EARGO, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 5,63 $
Average target price 10,50 $
Spread / Average Target 86,5%
EPS Revisions
Managers and Directors
Christian Gormsen President, Chief Executive Officer & Director
Adam Laponis Chief Financial Officer
Joshua Makower Non-Executive Chairman
Daniel Shen Chief Clinical & Science Officer
Fernando Cruz Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
EARGO, INC.-87.44%215
THERMO FISHER SCIENTIFIC34.98%247 742
DANAHER CORPORATION41.06%223 913
INTUITIVE SURGICAL, INC.24.86%121 636
SIEMENS HEALTHINEERS AG51.88%84 006
EDWARDS LIFESCIENCES CORPORATION22.72%72 123